These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11934344)

  • 1. Treatment options for renovascular hypertension.
    Spence JD
    Expert Opin Pharmacother; 2002 Apr; 3(4):411-6. PubMed ID: 11934344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy of renovascular hypertension.
    Rosenthal T
    Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
    Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
    Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converting enzyme inhibitors and renal function in essential and renovascular hypertension.
    Mimran A; Ribstein J; DuCailar G
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):7S-14S. PubMed ID: 2009153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
    Burnier M; Waeber B; Nussberger J; Brunner HR
    J Hypertens Suppl; 1989 Sep; 7(7):S27-31. PubMed ID: 2693654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe hypertension in a 14-year-old child: Successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension.
    Zhang X; Xu Y; Chen X; Wang S; Li X; Yan X
    Clin Exp Hypertens; 2017; 39(7):587-591. PubMed ID: 28621587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses.
    Hricik DE; Dunn MJ
    J Am Soc Nephrol; 1990 Dec; 1(6):845-58. PubMed ID: 2103846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis.
    Pipinos II; Nypaver TJ; Moshin SK; Careterro OA; Beierwaltes WH
    J Vasc Surg; 1998 Jul; 28(1):167-77. PubMed ID: 9685143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renovascular hypertension].
    Sugita A
    Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):641-9. PubMed ID: 2526891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension.
    Hackam DG; Spence JD; Garg AX; Textor SC
    Hypertension; 2007 Dec; 50(6):998-1003. PubMed ID: 17923585
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension.
    Jackson B; McGrath BP; Matthews PG; Wong C; Johnston CI
    Hypertension; 1986 Aug; 8(8):650-4. PubMed ID: 3015794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renovascular hypertension: is it only the top of the iceberg?].
    Lewandowski J
    Pol Merkur Lekarski; 2003 Oct; 15(88):371-5; discussion 375-6. PubMed ID: 14974369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension therapy in patients with renal artery stenosis].
    Vogt B; Maillard M; Burnier M
    Ther Umsch; 2012 May; 69(5):279-81. PubMed ID: 22547359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists.
    Picciotto G; Sargiotto A; Petrarulo M; Rabbia C; De Filippi PG; Roccatello D
    J Nucl Med; 2003 Oct; 44(10):1574-81. PubMed ID: 14530469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension.
    Hannedouche T; Godin M; Fries D; Fillastre JP
    Nephron; 1991; 57(2):230-1. PubMed ID: 2020353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renovascular hypertension: an update.
    Elliott WJ
    J Clin Hypertens (Greenwich); 2008 Jul; 10(7):522-33. PubMed ID: 18607138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
    Alhadad A; Sterner G; Herlitz H
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.